STI571: a magic bullet?

被引：29

作者：

Verweij, J ^{[1
]}

Judson, I

van Oosterom, A

机构：

[1] Rotterdam Canc Inst, Daniel Den Hoed Klin, Dept Med Oncol, Rotterdam, Netherlands

[2] Univ Rotterdam Hosp, Rotterdam, Netherlands

[3] Royal Marsden Hosp, Dept Med Oncol, Sutton, Surrey, England

[4] Univ Hosp Gasthuisberg, Dept Oncol, B-3000 Louvain, Belgium

来源：

EUROPEAN JOURNAL OF CANCER | 2001年 / 37卷 / 15期

关键词：

D O I：

10.1016/S0959-8049(01)00237-4

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：1816 / 1819

页数：4

共 16 条

[1]

ABELSON HT, 1970, CANCER RES, V30, P2213

[2]

Blanke CD, 2001, P AM SOC CLIN ONCOL, p1a

[3]

Buchdunger E, 1996, CANCER RES, V56, P100

[4]

Buchdunger E, 2000, J PHARMACOL EXP THER, V295, P139

[5] CGP 57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-ABL, TEL-ABL, and TEL-PDGFR fusion proteins [J].

Carroll, M ;

OhnoJones, S ;

Tamura, S ;

Buchdunger, E ;

Zimmermann, J ;

Lydon, NB ;

Gilliland, DG ;

Druker, BJ .

BLOOD, 1997, 90 (12) :4947-4952

[6]

DEISSEROTH AB, 1994, CANC PRINCIPLES PRAC, P1965

[7] Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the philadelphia chromosome. [J].

Druker, BJ ;

Sawyers, CL ;

Kantarjian, H ;

Resta, DJ ;

Reese, SF ;

Ford, JM ;

Capdeville, R ;

Talpaz, M .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1038-1042

[8] Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. [J].

Druker, BJ ;

Talpaz, M ;

Resta, DJ ;

Peng, B ;

Buchdunger, E ;

Ford, JM ;

Lydon, NB ;

Kantarjian, H ;

Capdeville, R ;

Ohno-Jones, S ;

Sawyers, CL .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1031-1037

[9] Gastrointestinal stromal tumors: Their origin and cause [J].

Hirota S. .

International Journal of Clinical Oncology, 2001, 6 (1) :1-5

[10] Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. [J].

Joensuu, H ;

Roberts, PJ ;

Sarlomo-Rikala, M ;

Andersson, LC ;

Tervahartiala, P ;

Tuveson, D ;

Silberman, SL ;

Capdeville, R ;

Dimitrijevic, S ;

Druker, B ;

Demetri, GD .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1052-1056

← 1 2 →